Q3 2025 Earnings Call Transcript October 29, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Vanda Pharmaceuticals and the FDA have agreed to lay down their swords, squashing years of legal disputes with an agreement that will see regulatory action on much of Vanda’s grievances. The ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Stifel 2025 ...

With a pair of new athletic partnerships under its belt, Vanda Pharmaceuticals is suiting up as a multisport player. Already this year, the Washington, D.C.-based drugmaker signed on as a jersey patch ...

Vanda Pharmaceuticals has agreed to a plan in which the Food and Drug Administration will conduct more reviews of two of its drugs to resolve disputes between the company and the agency. Under the ...

The New York Islanders today announced a multi-year agreement with Vanda Pharmaceuticals, a global biopharmaceutical company, naming them the team’s exclusive jersey patch partner. This landmark ...

ARLINGTON, Va. –The Washington Capitals today announced a partnership with Vanda Pharmaceuticals that will see the leading Washington, D.C. based global pharmaceutical company as the official partner ...